Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

Epithelial-mesenchymal transition (EMT) is a physiological process that has been recognized to occur during the progression of an increasingly large number of human diseases, including liver fibrosis, cirrhosis, and hepatocellular carcinoma. The activation of transforming growth factor β (TGF-β) sig...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autors principals:	Yue‐Lei Chen, Jing Lv, Xiaolei Ye, Mingyu Sun, Qin Xu, Chenghai Liu, Lihua Min, Huiping Li, Ping Liu, Xiaoyan Ding
Format:	Artigo
Idioma:	anglès
Publicat:	2011
Accés en línia:	https://doi.org/10.1002/hep.24254 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.24254
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells
per: Zhang, Juyong, et al.
Publicat: (2013)

Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
per: Tomoyuki Nagai, et al.
Publicat: (2011)

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
per: Yanru Deng, et al.
Publicat: (2016)

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
per: Deng, Yan-Ru, et al.
Publicat: (2016)

The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
per: Zhang, Kun, et al.
Publicat: (2019)

The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
per: Kun Zhang, et al.
Publicat: (2019)

Histone deacetylase inhibition suppresses the transforming growth factor β1-induced epithelial-to-mesenchymal transition in hepatocytes
per: Aki Kaimori, et al.
Publicat: (2010)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
per: Yi‐Lang Chen, et al.
Publicat: (2013)

Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
per: Chen, Weibo, et al.
Publicat: (2019)

PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition
per: Liu, Hongyu, et al.
Publicat: (2019)

Autophagy regulates hepatocyte identity and epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions promoting Snail degradation
per: Germana Grassi, et al.
Publicat: (2015)

SYNCRIP Modulates the Epithelial-Mesenchymal Transition in Hepatocytes and HCC Cells
per: Riccioni, Veronica, et al.
Publicat: (2022)

Hypoxia Stimulates Hepatocyte Epithelial to Mesenchymal Transition by Hypoxiainducible Factor- and Transforming Growth Factor-β-dependent Mechanisms
per: Copple, Bryan L.
Publicat: (2010)

Melatonin Inhibits Transforming Growth Factor-β1-Induced Epithelial–Mesenchymal Transition in AML12 Hepatocytes
per: Kim, Jung-Yeon, et al.
Publicat: (2019)

Regorafenib reverses <scp>HGF</scp>‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
per: Weibo Chen, et al.
Publicat: (2018)

Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-β-Induced Epithelial-Mesenchymal Transition
per: Jia, Lining, et al.
Publicat: (2015)

Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
per: Taura, Kojiro, et al.
Publicat: (2010)

Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice
per: Kojiro Taura, et al.
Publicat: (2009)

Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-β-dependent mechanisms
per: Bryan L. Copple
Publicat: (2010)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
per: Chen, Y-L, et al.
Publicat: (2013)

Dual role of RACK1 in airway epithelial mesenchymal transition and apoptosis
per: Pu, Yue, et al.
Publicat: (2020)

A Novel Mechanism by which Hepatocyte Growth Factor Blocks Tubular Epithelial to Mesenchymal Transition
per: Junwei Yang, et al.
Publicat: (2004)

Corrigendum to: Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
Publicat: (2022)

FZD5 prevents epithelial-mesenchymal transition in gastric cancer
per: Dong, Dan, et al.
Publicat: (2021)

MicroRNA-101 inhibits renal tubular epithelial-to-mesenchymal transition by targeting TGF-β1 type I receptor
per: Wang, Qinglan, et al.
Publicat: (2021)

Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transition
per: Tian, Chuntao, et al.
Publicat: (2022)

Hepatitis C Virus Induces Epithelial-Mesenchymal Transition in Primary Human Hepatocytes
per: Bose, Sandip K., et al.
Publicat: (2012)

Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
per: Michael Zeisberg, et al.
Publicat: (2007)

Hepatitis C Virus Induces Epithelial-Mesenchymal Transition in Primary Human Hepatocytes
per: Sandip K. Bose, et al.
Publicat: (2012)

Human lens epithelial cell apoptosis and epithelial to mesenchymal transition in femtosecond laser-assisted cataract surgery
per: Sun, Wei, et al.
Publicat: (2018)

C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells
per: Ji, Huanhuan, et al.
Publicat: (2020)

KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition
per: Hu, Bo, et al.
Publicat: (2019)

Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
per: Liao, Li-Zhu, et al.
Publicat: (2020)

Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells
per: Xu, Gui-Li, et al.
Publicat: (2020)

Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
per: Li-Zhu Liao, et al.
Publicat: (2020)

Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells
per: Padilla-Nash, Hesed M., et al.
Publicat: (2013)

Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-β1 signal transduction pathway in vivo and in vitro
per: Qinglan Wang, et al.
Publicat: (2010)

ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression
per: Lahsnig, C, et al.
Publicat: (2008)

Murine Cirrhosis Induces Hepatocyte Epithelial Mesenchymal Transition and Alterations in Survival Signaling Pathways
per: Nitta, Takashi, et al.
Publicat: (2008)

Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways
per: Takashi Nitta, et al.
Publicat: (2008)